Trastuzumab: a novel standard option for patients with HER-2-positive advanced gastric or gastro-oesophageal junction cancer. [electronic resource]
Producer: 20120921Description: 301-18 p. digitalISSN:- 1756-2848
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.